Cargando…
CMTM7 recognizes an immune-hot tumor microenvironment and predicts therapeutic response of immunotherapy in breast cancer well
Breast cancer (BRCA) is a complex disease that leads to major mortalities and unsatisfactory clinical outcomes among women worldwide. CKLF-like MARVEL transmembrane domain-containing 7 (CMTM7) is a potential tumor suppressor and regulator of PD-L1, which has been found as a functional signature in c...
Autores principales: | Jiang, Xingyu, Qian, Zhengtao, Chen, Yu, Zhou, Tao, Zhao, Can, Yin, Yongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770089/ https://www.ncbi.nlm.nih.gov/pubmed/36568362 http://dx.doi.org/10.3389/fgene.2022.1051269 |
Ejemplares similares
-
PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy
por: Wu, Cen, et al.
Publicado: (2022) -
CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
por: Zhang, Tong, et al.
Publicado: (2022) -
Quantitative analysis of CMTM6 expression in tumor microenvironment in metastatic melanoma and association with outcome on immunotherapy
por: Martinez-Morilla, Sandra, et al.
Publicado: (2020) -
Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022) -
Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification
por: Zhang, Mengjun, et al.
Publicado: (2022)